HKD 0.09
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -103.71 Million | -88.01 Million | -475.2 Million | -26.18 Million | 211.31 Million | -64.49 Million |
Net Income | 3.74 Billion | -1.57 Billion | -409.46 Million | -2.41 Billion | -1.07 Billion | -1.36 Billion |
Depreciation & Amortization | 241.81 Million | 330.5 Million | 402.51 Million | 456.92 Million | 504.95 Million | 502.95 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 291.79 Million | 413.9 Million | 38.11 Million | 566.33 Million | 816.83 Million | 500.07 Million |
Other non-cash items | -3.79 Billion | 741.35 Million | -506.36 Million | 1.36 Billion | -33.85 Million | 299.58 Million |
Investing Cash Flow | -14.37 Million | -413 Thousand | 392.59 Million | 120.09 Million | -52.47 Million | 18.8 Million |
Investments in PPE | -43.77 Million | -6.17 Million | -25.81 Million | -16.83 Million | -51.42 Million | -168.73 Million |
Acquisitions | 29.4 Million | 5.76 Million | 418.4 Million | -1000.00 | -6.13 Million | 18.01 Million |
Investment purchases | - | - | - | - | -208 Thousand | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 29.4 Million | 5.76 Million | 418.27 Million | 136.92 Million | 5.29 Million | 169.52 Million |
Financing Cash Flow | 165.81 Million | 109.75 Million | -48.65 Million | -25.87 Million | -263.14 Million | -116.41 Million |
Debt repayment | -167.72 Million | -68.94 Million | -404.26 Million | -365 Million | -3.77 Billion | -3.87 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 132.69 Million | 127.98 Million | - |
Other Financing Activities | 114.53 Million | 178.69 Million | 355.61 Million | 206.44 Million | 3.38 Billion | 3.75 Billion |
Accounts receivables | -152.04 Million | 47.03 Million | 21.3 Million | 119.2 Million | 310.73 Million | -142.1 Million |
Accounts payables | 21.55 Million | 114.1 Million | -216.28 Million | -285.97 Million | -569.3 Million | 629.43 Million |
Inventory | 25.35 Million | -142.13 Million | 36.06 Million | 243.44 Million | 424.94 Million | -125.35 Million |
Other working capital | 396.93 Million | 394.9 Million | 197.02 Million | 489.65 Million | 650.46 Million | 138.09 Million |
Cash at beginning of period | 41.93 Million | 21.81 Million | 153.32 Million | 79.5 Million | 135.03 Million | 304.36 Million |
Cash at end of period | 88.35 Million | 41.76 Million | 21.81 Million | 153.32 Million | 79.5 Million | 135.03 Million |
Capital Expenditure | -43.77 Million | -6.17 Million | -25.81 Million | -16.83 Million | -51.42 Million | -168.73 Million |
Effect of forex changes on cash | -1.3 Million | -1.37 Million | -238 Thousand | 5.77 Million | 48.77 Million | -7.23 Million |
Net cash flow / Change in cash | 46.41 Million | 19.95 Million | -131.51 Million | 73.81 Million | -55.52 Million | -169.32 Million |
Free Cash Flow | -147.48 Million | -94.18 Million | -501.01 Million | -43.01 Million | 159.88 Million | -233.23 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -157.74 Million | 3.8 Billion | 3.74 Billion | -64.9 Million | -1.57 Billion | -656.12 Million |
Depreciation & Amortization | 135.41 Million | 78.47 Million | 241.81 Million | 163.34 Million | 330.5 Million | 158.65 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -38 Million | 237.7 Million | 291.79 Million | 54.09 Million | 413.9 Million | 101.08 Million |
Other non-cash items | 51.61 Million | -4.01 Billion | -3.79 Billion | 225.42 Million | 741.35 Million | 610.82 Million |
Investing Cash Flow | - | -13.21 Million | -14.37 Million | -1.15 Million | -413 Thousand | 39 Thousand |
Investments in PPE | - | -42.74 Million | -43.77 Million | -1.03 Million | -6.17 Million | -5.72 Million |
Acquisitions | - | 29.4 Million | 29.4 Million | - | 5.76 Million | 5.76 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 120 Thousand | 29.4 Million | -120 Thousand | 5.76 Million | 5.76 Million |
Financing Cash Flow | -12.05 Million | -8.86 Million | 165.81 Million | 174.67 Million | 109.75 Million | 147.35 Million |
Debt repayment | -1.73 Billion | - | -167.72 Million | -175.55 Million | -68.94 Million | -148.4 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 1.72 Billion | - | - | - | - | - |
Other Financing Activities | -373 Thousand | -8.86 Million | 114.53 Million | 170.79 Million | 178.69 Million | 140.06 Million |
Accounts receivables | 59.56 Million | -68.83 Million | -152.04 Million | -83.2 Million | 47.03 Million | -3.3 Million |
Accounts payables | 185.92 Million | 98.12 Million | 21.55 Million | -76.57 Million | 114.1 Million | 147.07 Million |
Inventory | -159.54 Million | 65.56 Million | 25.35 Million | -40.21 Million | -142.13 Million | -157.64 Million |
Other working capital | -123.94 Million | 142.85 Million | 396.93 Million | 254.07 Million | 394.9 Million | 114.95 Million |
Cash at beginning of period | 88.35 Million | 63.67 Million | 41.93 Million | 41.93 Million | 21.81 Million | 14.81 Million |
Cash at end of period | 66.25 Million | 88.35 Million | 88.35 Million | 63.79 Million | 41.76 Million | 41.93 Million |
Capital Expenditure | - | -42.74 Million | -43.77 Million | -1.03 Million | -6.17 Million | -5.72 Million |
Effect of forex changes on cash | - | - | -1.3 Million | -2.94 Million | -1.37 Million | -3.5 Million |
Net cash flow / Change in cash | -22.1 Million | 24.67 Million | 46.41 Million | 21.85 Million | 19.95 Million | 27.12 Million |
Free Cash Flow | -8.71 Million | 2.26 Million | -147.48 Million | -149.75 Million | -94.18 Million | -122.47 Million |
PLIN
1558
CARM
KIDZ
APTECHT
FMV